Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.2000
+0.1900 (1,900.00%)
At close: Aug 28, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $354.98 thousand as of August 31, 2026. Its market cap has decreased by -96.93% in one year.
Market Cap
354.98K
Enterprise Value
14.72M
Revenue
398.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
ChartMarket Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 354.98K, a decrease of -99.85%. That is a compound annual growth rate of -64.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 354.98K | -93.51% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nextel Medical | 552.41K |
| THC Farmaceuticals | 505.87K |
| inTerra Resources | 458.51K |
| Mosaic ImmunoEngineering | 441.77K |
| Altamira Therapeutics | 400.08K |
| Actavia Life Sciences | 385.91K |
| Ocean Biomedical | 325.31K |
| NKGen Biotech | 274.27K |